Continuing Professional Development

The ECPM Continuing Professional Development (CPD) platform provides accredited high quality educational programs to support continuing medical education and professional development for physicians, and pharmaceutical industry, regulatory and university professionals. As such, its primary intention is to provide up-to-date knowledge on current trends in drug development and to train drug development professionals for their next career step. Additionally, it offers a platform to share knowledge with colleagues and discuss with experts face-to-face. Our services include a broad range of CPD short courses that cover all skills across the drug development process. These CPD short courses count towards the Master program, yet they are also a stand-alone offer and can be booked individually to shape your professional skills and are offered in the following formats:

Short Courses/Workshops - A range of interactive onsite short courses/workshops. These cover a broad curriculum within the drug development process - from educational seminars to soft skills.

Frontiers in Drug Development Seminar - One day onsite seminars on new trends in drug development science.

E-Learning -Selected e-learning courses that provide an interactive environment for self-paced learning and can be booked at any time.

Study Trips - Yearly international study trips. A total of six study half-days are planned, which allow participants to experience a mix of theory and visits to institutions.

Courses offered by other Course Providers - Co-organized courses with other institutions, such as the University Hospital of Basel or partner universities. In addition, students also have the opportunity to choose courses offered by PharmaTrain Recognized Course Providers.

If you are interested in receiving information about our courses please subscribe to our ECPM newsletter.

10.02.2022 08:30

The Right Dose for Every Patient (ONLINE)

More Information

The Right Dose for Every Patient

Characterizing the dose response relationship and subsequent determination of an adequate dose level in humans are key objectives in the development of a medicinal product. Dose finding studies and modeling and simulation techniques play a key role in the transition of a drug from the non-clinical to the clinical phase and represent the gatekeeper for first in human studies and large confirmatory clinical trials.

With the rise of precision medicine comes a promise for greater dose flexibility to further improve efficacy and reduce adverse effects. Some groups in the population require special clinical studies due to specific dosing, pharmacokinetics and administration characteristics. The use of medicines in the elderly requires special consideration due to the frequent occurrence of underlying diseases and the consequent risk of medicines interaction of the various treatment regimens. Gender and sex are important drivers of phenotypic variability in patient populations. Microdosing studies offer the possibility to study the mechanism of action and pharmacodynamics with sub-therapeutic exposure.

The seminar is designed to provide an overview of current concepts in non-clinical and clinical pharmacology and drug dosing with special consideration of the individual patient and the predisposition of special populations. We look forward to welcoming you and your colleagues on 10 February, 2022!

About Frontiers in Drug Development Seminars

ECPM offers one day seminars on current topics, new trends and developments in drug development science. These seminars provide the opportunity to integrate work and further education, to discuss with experts face-to-face and to build an international network. They take place on the fourth day of each of the six modules of the Diploma Course and are mandatory for students taking the Diploma Course. Additionally they are open to our alumni and other interested scientists and can be booked separately.

Learning Outcomes

Participants will learn about the:

  • Future trends in drug development including Future Information Technologies, Nano-Technologies, Computer Simulation and Modelling, Personalised Medicine, Genomics, Biologicals and Biosimilars, Advanced Therapeutics
  • Regulatory Agency updates from FDA, EMA and Swissmedic
  • Ethical, Economic and Epidemiological Considerations and Concepts in Drug Development

Language

English

Program

One-day workshops, recognised for continuing professional development. The workshops are held on day four of each ECPM Course Module.

Credits

Accredited as continuing education by the Swiss Society of Pharmaceutical Medicine (SGPM), FPH SPITAL and the Swiss Society of Pharmaceutical Professionals (SwAPP).

Fee

Course fee including certificate and electronic course material is CHF 280 and CHF 180 for ECPM Alumni and SwAPP/SGPM members. A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in writing before the deadline for registration, after this date no refund can be given. Speakers are subject to change without notice.

Date and Venue

Thursday, February 10, 2022
Online

Deadline for Registration

30 January, 2022

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Registration
Methodological concepts of health economics
24.03.2022 08:00

Fundamentals in Health Economics

More Information

Course Description

This course intends to provide the participants with an understanding of the key principles and methodological concepts of health economics. The role of health-economic thinking in the drug development process is addressed. Two group exercises will complement lectures and discussions.

Course Program

The program includes theoretical background sessions and is enriched with exercises and in-group exercises

  • Basic economic concept and principles
  • Health economic evaluations principles and methods
  • Health economic evaluation in drug development
  • Health technology assessments and reimbursement
  • Health economic evaluation alongside clinical trials and the need for modelling
  • Budget impact analysis – relevance, principles, and relationship with cost-effectiveness analysis

Learning Outcomes

At the end of the course, the participants will

  • Understand the fundamental concepts of health economics.
  • Understand key principles of health economic evaluation.
  • Be able to assess and appraise a published health economic analysis according to guidelines and checklists.
  • Understand the importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance.
  • Understand how policymakers set priorities in health care and how health economic evaluations support this process
  • Understand the importance of health technology assessment in different health care systems.
  • Understand rational choice and priority setting using economic evaluation.

Course Faculty

Prof. Thomas D. Szucs, MD MPH MBA LLM
Prof. Matthias Schwenkglenks, PhD MPH
Michaela Barbier, PhD
Arjun Bhadhuri, PhD
Paola Salari, PhD
Speakers from Pharmaceutical Industry

Target Audience

All pharmaceutical and health care professionals who are interested in getting a fundamental understanding of health economics and health economic evaluations in the context of drug development.

Course Language

English

    Course Credits

    The course including assessment provides 2 ECTS credits.

    Course Date and Venue

    March 24-25, 2022

    Course Fee

    Course fee including certificate and electronic course material is CHF 1400.
    A reduced fee applies to participants from academia and nonprofit organizations.

    Cancellation Policy

    Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

    Deadline for Registration

    March 4, 2022

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration
    28.04.2022 08:00

    Scientific Medical Writing

    More Information

    Course Description

    Brush up your scientific and medical writing skills. Learn how to structure scientific papers and reports and write a clear and informative scientific text. This course provides a comprehensive overview of the strategic scientific and medical writing field and offers hands-on training in writing and analyzing scientific texts.

    Course Program

    This course will cover:

    • What is the correct strategic approach to writing successful documents
    • How to convey a message to the target audience
    • How to produce high-quality documents
    • What are the requirements to reach a successful outcome
    • Ethics of scientific writing
    • Practical work with multiple exercises

    Learning Outcomes

    By the end of the course, students will be able to:

    • Know key elements of good medical and scientific writing
    • Critically appraise texts and identify elements of poor writing
    • Convert some examples of poor writing to good scientific writing
    • Reproduce the most important aspects of good medical and scientific writing
    • Improve own texts

    Course Faculty

    Dr. Silvia M. Rogers, MEDIWRITE, Basel, Switzerland

    Target Audience

    This course is for all professionals (native or non-native English speakers) who intend to improve their scientific medical writing skills.

    Course Language

    English

    Course Credits

    The course including homework provides 1 ECTS credit.
    100 FPH credit points in hospital pharmacy (accreditation to be submitted)

    Course Date and Venue

    April 28-29, 2022
    University of Basel

    Course Fee

    Course fee including certificate, electronic course material, book by Silvia Rogers, lunch and coffee breaks is 1300 CHF.
    A reduced fee applies to participants from academia and nonprofit organizations.

    Cancellation Policy

    Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

    Deadline for Registration

    April 14, 2022

    Course Organizer

    This course is organized by the European Center of Pharmaceutical Medicine.

    Registration
    ECPM Presentation and communicationSkill
    12.05.2022 08:00

    Communicating more Powerfully and Persuasively

    More Information

    Course Description

    This course is an intense two-day interactive, hands-on program designed to build and expand essential presentation skills from both content and delivery perspectives. Participants will learn how to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

    Participants should come ready to deliver a ten-minute presentation as well as a short story about a project in which they have been involved. Crucially, the story must include the type of obstacles that were faced, how they were overcome, the people or factors that helped or hindered along the way, together with the successes and failures and the outcome. Feedback from peers and the facilitators will help participants improve their ability to connect from both content and delivery perspectives.

    Course Program

    Day 1 – The process, establishing a baseline, stakeholders and messaging

    • Introduction to developing powerful presentations
    • Participants will deliver two presentations and receive direct feedback
    • Stakeholder definition, prioritization and analysis
    • Development of key messages

    Day 2 – Storytelling, creating a narrative, and Q&A

    • Storytelling techniques
    • Structure and storyboard a presentation to address key stakeholders
    • Media techniques to confidently handle question and answer sessions
    • Delivery of final presentations by participants

    Learning Outcomes

    By the end of the course, participants will have a better understanding of how to:

    • Present in a more compelling way to internal and external stakeholders with increased confidence and capability
    • Use skills and techniques to:
      • Translate complex concepts into scalable and tailored messages for stakeholders
      • Develop engaging narratives using storytelling models that showcase and differentiate their science/project
      • Speak effectively to groups of any size face-to-face and online
      • Confidently handle question and answer sessions

    Course Faculty

    O’Patrick Wilson and Jennifer Sgueglia, O public relations GmbH, Ettingen, Switzerland

    Target Audience

    The course is designed for participants who want to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

    Course Language

    English

      Course Credits

      The course including assessment provides 2 ECTS credits. The course is accredited with 100 FPH-points in hospital pharmacy by the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

      Course Date and Venue

      May 12-13, 2022
      University of Basel

      Course Fee

      Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 1800.
      A reduced fee applies to participants from academia and nonprofit organizations.

      Cancellation Policy

      Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

      Deadline for Registration

      April 12, 2022

      Course Organizer

      This course is organized by the European Center of Pharmaceutical Medicine.

      Registration
      ECPM Study Trip 2021
      Study Trip 2022 to Estland
      14.05.2022 05:00

      Study Trip 2022 to Estland

      More Information

       

      Background

      After the trips to Singapore (2015, 2016), Israel (2017), Denmark (2018), and Canada (2019) the destination of the study trip 2022 is Estland.

      Brochure

      Brochure will be available soon

      Program

      A total of six study half-days are planned (theory and visits to institutions). The program will be available soon.

      • Introduction into the health system
      • Visits of hospitals
      • Insurance companies
      • Pharmaceutical industry

      Participants

      The study trip is intended for all experts working in public healthcare services. Minimum number of participants: 12 persons.

      Credits

      The trip provides 3 ECTS credits (rewarded after assignment has been accepted)

      Study Trip Fees

      Price varies according to country, registration and management via Max Künzi, 10% rebate for ECPM students. We reserve the right to change the program and/or the prices anytime.

      Registration

      For more information and registration please contact

      Contact

      Lic. iur. Max Künzi, MM | SAGG/SAHE | c/o Künzi Beratungen | Schachenstrasse 21 | Postfach 201 | 4702 Oensingen T (+41)(0)62 396 10 49 | F (+41)(0)62 396 24 10 | | www.sagg-sahe.ch | in cooperation with a travel agency.

      ECPM Project Management in the Life Sciences Industry
      19.09.2022 08:00

      Project Management in the Life Sciences Industry

      More Information

      Course Description

      This course, offered in two parts of three days each, focuses on projects in the life sciences industry and the clinical trial setting, with the aim of bringing new treatments to patients successfully.

      These projects can range from early pre-clinical projects, to managing toxicology and Entry Into Human studies, large phase III clinical trials and post-marketing studies. All of them share a high complexity and require professional management at every level by experienced project managers who know the processes to reach the deliverables, can deal with multiple stakeholders simultaneously and deliver projects successfully often under a tight given budget and timelines.

      This highly interactive workshop setting includes a mixture of instructor led training and group work on real life cases. All templates and tools for planning, executing, managing & controlling as well as closing a project will be developed. In addition participants have the opportunity to discuss and work on an own project, identify its challenges and develop solutions or work on a model project provided by the course instructors.

      Course Program

      This course consists of two parts of three days each. A variety of teaching methods including lectures, exercises and interactive group discussions will be applied. A mandatory home assignment will complete the learning portfolio.

      The course covers the following topics:

      • Discussion of all project phases (initiation, planning, execution, monitoring & controlling, closure) and knowledge areas
      • Management of scope, time, cost, quality, team, communication, risk, procurement and stakeholders
      • Development of a project plan, starting from a project charter
      • Creation of documents and worksheets for managing clinical trials or other projects relating to pharmaceutical development
      • Discussion of Key Performance Indicators (KPIs) for project status
      • Discussion of Corrective Action Preventive Action (CAPAs) to prevent the project from getting off track

      Learning Outcomes

      At the end of the course, participants will

      • Understand the tasks and responsibilities of a project manager
      • Know the major project documents required for conducting projects successfully
      • Be acquainted with the tools to manage all knowledge areas throughout all project phases
      • Build, lead and manage effective project teams
      • Be familiar with the interactions needed with different project stakeholders
      • Have a series of templates and tools at hand
      • Be able to use and/or adapt these templates and tools within individual projects
      • Know how to practically apply different project management standards to all kinds of pharmaceutical development projects

      Course Faculty

      Adam Sobanski, MAIN5 Management Consulting, Frankfurt am Main, Germany

      Target Audience

      Specialists responsible for projects in the pharmaceutical industry, hospital or academic setting or regulatory authority. The course not only provides the tools and fundamentals for successful project management but also illustrates real life cases. Experienced managers are encouraged to bring their current issues so that solutions can be compiled during the course.

      Course Language

      English

        Course Credits

        The course including assessment provides 4 ECTS credits.

        Course Date and Venue

        • Part 1: September 19-21, 2022
        • Part 2: October 17-19, 2022

        Course Fee

        Course fee including electronic course material, templates, lunch and coffee breaks is CHF 3000.
        A reduced fee applies to participants from academia and nonprofit organizations.

        Cancellation Policy

        Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

        Deadline for Registration

        August 26, 2022

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration
        07.11.2022 08:30

        Ethical and Legal Aspects of Clinical Trials

        More Information

        Course Description

        The implementation of clinical research projects requires conscientious review of research projects not only in terms of their scientific quality but also in regard to their ethical adequacy and appropriateness. How can we balance the risk-benefit of our projects? Given the importance of ethics for the conduct of drug development and research, it should come as no surprise that many different professional associations, government agencies, and universities have adopted specific codes, rules, and policies relating to research ethics.

        Each of these aspects will be carefully considered and discussed in the context of international and national principles and guidelines. These issues need to be carefully adhered to strengthen the health of the clinical trial enterprise to the benefit of patients and the overall health of the public. During our course, representatives from different institutions will introduce and discuss the most important concepts, tools, principles, and methods that can be useful in approaching and resolving ethical dilemmas. Realworld examples and case studies will be introduced and discussed.

        Course Program

        Day 1
        The Evolution of Biomedical Research Ethics / Risk-Benefit Considerations of Research Interventions / Role of Ethics Committees / Successful Submission to an Ethics Committee / Coordinating Human Research in Switzerland / How to Design an Informed Consent / Ethical Review Systems in Europe and European Legislation / Ethics Committees’ Role in Reviewing Safety Information

        Day 2
        Equipoise / Transparency in Clinical Trials / Common Technical Document / Confidentiality and Intellectual Property / Personal Data Protection / Inducement in Clinical Research – from Recruitment Advertisement to Subject Compensation / Role of Patient Organisations in Clinical Trials (EUPATI) / Public Health Ethics (incl. biobanks)

        Day 3
        Ethical Aspects of Clinical Research in Children / Informed Consent Process in Pediatric Patients / Clinical Research in Vulnerable Populations / Misconduct and Fraud, Research Integrity / ICH E6 Regulation / Legal and Ethical Framework for Genetic Testing

        Learning Outcomes

        By the end of the course, students will be able to:

        • Name key principles of ethical considerations during clinical research and development
        • Discuss ethical concerns for designing, conducting and reporting the results obtained through the conduct of clinical trials
        • Understand international and national principles and guidelines which have to be followed when performing clinical trials

        Course Faculty

        tba

        Target Audience

        All pharmaceutical and health care professionals who are interested in getting a deeper understanding of ethical and legal aspects in medicines development.

        Course Language

        English

        Course Credits

        The course including assessment provides 2 ECTS credits.

        Course Date and Venue

        Basel, 7-9 November, 2022.

        Course Fee

        Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 2000.
        A reduced fee applies to participants from academia and nonprofit organizations.

        Cancellation Policy

        Refund of fee will be given if cancellation is received in written format () before the deadline for registration, after this date no refund can be given.

        Deadline for Registration

        October 14, 2022

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration
        ECPM European University Network
        ECPM partner universities in the European University Network
        01.01.2023 08:10

        Other Courses by Pharmatrain

        More Information

        Join courses run by our partner universities in the European University Network, which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus. For an overview of all PharmaTrain Recognized Course Providers please click here.

        E-Learning: Basics in Health Economics

        More Information

        Course Description

        This e-learning course provides an understanding of the key principles and methodological concepts of health economic evaluations. It is based on the well-established face-to-face course on health economics offered by the ECPM. The scientific content was developed by Prof. Thomas Szucs and Prof. Matthias Schwenkglenks as well as other specialists from the field.

        Learning Outcomes

        At the end of the course, the participants should be able to describe:

        • Fundamental concepts of health economics
        • Key elements of health economic evaluation
        • Assessment and analysis of a published health economic study
        • The importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance
        • How policymakers set priorities in health care and how health economic evaluations support this process

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration

        E-learning: Drug Safety and Pharmacovigilance

        More Information

        Course Description

        This e-learning course provides an understanding of the safety-related aspects within the drug development process. These range from early preclinical testing, risk/benefit assessment up to clinical adverse event signal detection and monitoring.

        Learning Outcomes

        At the end of the course, the participants should be able to describe:

        • The role of drug safety in the successful development and usage of a medicine to the benefit of patients
        • Which safety-related questions need to be answered in early and late drug development
        • Tools, techniques, and methodologies used in drug safety evaluation
        • What frequent pitfalls related to drug safety considerations occur and why they can lead to discontinuation of drugs in development, label changes or even withdrawal of drugs from the market after launch
        • How changes in safety assessment could become part of a new drug development paradigm

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration

        E-Learning: Personalized Health Care

        More Information

        Course Description

        This e-learning course provides an understanding of the key principles and methodological concepts of personalized drug development. The role of individualized treatment strategies is addressed, including all relevant clinical, ethical and governmental aspects.

        Learning Outcomes

        At the end of the course, the participants should be able to:

        • Understand the biological and clinical concepts of personalized medicine
        • Understand the benefits and pitfalls of individualized therapies for patients
        • Comprehend the basic elements of predictive and prognostic interventions
        • Understand the role of surrogate endpoints and clinically validated biomarkers in personalized medicine
        • Understand pharmacogenetic and pharmacogenomic implications
        • Be aware of the strategies of R&D processes with personalized drugs
        • Understand the economics challenges of personalized medicine and how policymakers set priorities in individualized health care
        • Determine legal, regulatory and ethical aspects of personalised medicine

        Structure and Workload

        Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

        Course Language

        English

        Course Credits

        After successful completion of the e-learning course, 1 ECTS will be awarded (Certificate of Attendance from the University of Basel).

        Course Fee

        CHF 650
        A reduced fee applies to participants from academia and nonprofit organizations.

        Course Organizer

        This course is organized by the European Center of Pharmaceutical Medicine.

        Registration